What is the resultant ratio strength of an ointment prepared by combining 10 g of 10% betamethasone valerate ointment, 40 g of 5% betamethasone valerate ointment and 10 g of ointment base?

Gluconeogenesis is the metabolic pathway that generates glucose from non-carbohydrate substrates during periods of fasting or intense exercise. This process occurs mainly in the liver and kidneys to maintain blood glucose levels. Key substrates include glucogenic amino acids, lactate, and glycerol. It essentially reverses glycolysis but must bypass three irreversible enzymatic steps using specific mitochondrial and cytosolic enzymes.

Rationale:

A. Malate is an intermediate in the citric acid cycle and is used as a shuttle to transport oxaloacetate out of the mitochondria. While it is part of the gluconeogenic pathway, it is an intermediate rather than a primary starting "precursor" like lactate or amino acids. It is a transitional molecule in the carbon flux.

B. Fatty acids are generally not precursors for gluconeogenesis in humans because the pyruvate dehydrogenase reaction is irreversible. The acetyl-CoA produced from fatty acid oxidation cannot be converted back into pyruvate. Only the glycerol backbone of triacylglycerols can be converted into glucose, while the fatty acid chains cannot.

C. Pyruvate is the primary non-carbohydrate precursor that enters the gluconeogenic pathway. It can be derived from the deamination of alanine or the oxidation of lactate via the Cori cycle. Pyruvate is carboxylated to oxaloacetate, marking the commencement of the bypass reactions necessary to synthesize new glucose molecules.

D. Phosphoenolpyruvate (PEP) is a high-energy intermediate in both glycolysis and gluconeogenesis. It is the product of the PEP carboxykinase reaction during the bypass of the pyruvate kinase step. Because it is an intermediate formed during the process, it is not considered a primary external non-carbohydrate precursor.

SCHOLAR-MAC is a standardized patient assessment mnemonic used in community pharmacy and primary care to systematically evaluate a patient's self-reported symptoms. The "A" in the acronym stands for Aggravating factors, which are specific triggers that exacerbate the patient's discomfort. Identifying these factors helps the clinician distinguish between different pathological conditions and determine the appropriate level of intervention or referral.

Rationale:

A. Asking what makes the symptoms better addresses the Remediating factors of the clinical presentation. This information is valuable for understanding what treatments or positions provide relief, but it does not identify what causes the condition to worsen. It is the functional opposite of assessing aggravating triggers during the patient interview.

B. Asking "What makes the symptoms worse?" directly identifies aggravating factors. This question uncovers external or internal stimuli, such as specific foods, physical activities, or environmental exposures, that increase the severity of the illness. Pinpointing these triggers is essential for forming a differential diagnosis and providing effective lifestyle advice to the patient.

C. Asking when the symptoms started is used to assess the Onset of the condition. This helps the provider establish a timeline and determine if the issue is acute or chronic. While the timing is a critical component of the SCHOLAR assessment, it does not provide information regarding the factors that worsen the patient's distress.

D. Asking if this has happened in the past is part of the History section of the assessment. Understanding the recurrence of a symptom can indicate a chronic underlying problem or a pattern of seasonal triggers. However, a past occurrence is a temporal observation and does not explain the specific stimuli that aggravate the current episode.